The guidelines offer their endorsement of GLP-1s with a healthy degree of skepticism
Importantly, payer reimbursement restrictions are probably in place because previous cost-effectiveness analyses of these medications have considered at least some measure of their glycaemic benefits [13, 14], while whether SGLT2is and GLP-1 RAs are cost-effective solely on the basis of their benefits on cardiovascular and kidney disease has never been studied as far as we are aware
The value proposition is straightforward: purchasing BPC-157 and TB-500 individually at equivalent quantities would cost substantially more than the Wolverine Blend
Read More Afterwards, everyone returned to the drinking lab to repeat the process and see what had changed
GLP-1 users have also reported experiencing vision changes, erectile dysfunction, personality changes, increased reckless behavior and the infamous Ozempic butt and Ozempic boobs (sagging in all the wrong places)
- People who switched to orforglipron mostly their prior weight loss, while those on placebo started to regain a meaningful amount of weight, especially in the first 6 months
